Trials / Completed
CompletedNCT05235724
A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of Participants From PEDISTAD Study (OBS15333; NCT03687359)
Open-label 12-week Longitudinal Exploratory Study to Assess Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of PEDISTAD Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 6 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective: To explore and quantify the association between nighttime scratching and sleep patterns objectively in pediatric participants with moderate to severe atopic dermatitis (AD) using an innovative Emerald touchless sensor. Secondary objective: To evaluate the feasibility of using the Emerald touchless sensor in a pediatric clinical trial setting.
Detailed description
16 weeks
Conditions
Timeline
- Start date
- 2022-02-17
- Primary completion
- 2023-01-11
- Completion
- 2023-01-11
- First posted
- 2022-02-11
- Last updated
- 2023-01-31
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05235724. Inclusion in this directory is not an endorsement.